A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®
Completed
- Conditions
- Asthma
- Registration Number
- NCT00532922
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of this study is to investigate real practices of treatment with Symbicort Turbuhaler for 3 months in asthma and patient compliance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 310
Inclusion Criteria
- Provision of informed consent
- Asthmatics who has been prescribed Symbicort according to physician's judgement
- Usage of Symbicort should follow local prescribing information
Read More
Exclusion Criteria
- Not being involved in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site)
- No previous enrolment in the present study
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Site
🇨🇳Shanghai, China